PEGylation strategies for active targeting of PLA/PLGA nanoparticles

被引:121
作者
Betancourt, Tania [1 ]
Byrne, James D. [1 ]
Sunaryo, Nicole [1 ]
Crowder, Spencer W. [1 ]
Kadapakkam, Meena [1 ]
Patel, Shefali [1 ]
Casciato, Shelly [2 ]
Brannon-Peppas, Lisa [1 ]
机构
[1] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA
[2] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA
基金
美国国家科学基金会;
关键词
poly(ethylene glycol); poly(lactic-co-glycolic acid); poly(lactic acid); poloxamer; targeted delivery; PLA-PEG PARTICLES; PLGA NANOPARTICLES; BIODEGRADABLE POLYMERS; POLY(ETHYLENE GLYCOL); SURFACE MODIFICATION; PROTEIN CARRIERS; GENE DELIVERY; PLASMID DNA; COPOLYMERS; NANOSPHERES;
D O I
10.1002/jbm.a.32247
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
This work evaluates various techniques for the incorporation of poly(ethylene glycol) (PEG) onto biodegradable nanoparticles (NPs) of poly(lactic-co-glycolic acid) (PLGA) or poly(lactic acid) (PLA) with the purpose of providing a functional site for surface conjugation of targeting agents and for improving surface properties. The techniques compared were based on NP preparation with blends of PLGA and poloxamer or with block copolymers of PLGA/PLA with PEG. Blending of PLGA with poloxamer 407 resulted in the incorporation of the latter to up to a 43 wt % content. Direct conjugation of heterofunctional NH2-PEG-COOH to the surface of pre- made NPs was not highly effective. Preparation of copolymers of PLGA with PEG was determined to be more effective and versatile by polymerization of lactide and glycolide dimers onto the hydroxyl group of heterofunctional OH-PEG-COOH than by conjugation of the premade polymers with carbodiimide chemistry. NPs prepared with these copolymers confirmed the surface localization of PEG and proved to be useful for conjugation of mouse immumoglobulin as a model targeting agent. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 91A: 263-276, 2009
引用
收藏
页码:263 / 276
页数:14
相关论文
共 53 条
[1]   Freeze-drying of nanoparticles: Formulation, process and storage considerations [J].
Abdelwahed, Wassim ;
Degobert, Ghania ;
Stainmesse, Serge ;
Fessi, Hatem .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (15) :1688-1713
[2]  
[Anonymous], [No title captured]
[3]   Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles [J].
Avgoustakis, K ;
Beletsi, A ;
Panagi, Z ;
Klepetsanis, P ;
Livaniou, E ;
Evangelatos, G ;
Ithakissios, DS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 259 (1-2) :115-127
[4]  
Avgoustakis Konstantinos, 2004, Current Drug Delivery, V1, P321, DOI 10.2174/1567201043334605
[5]   Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method [J].
Barichello, JM ;
Morishita, M ;
Takayama, K ;
Nagai, T .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (04) :471-476
[6]   Effect of preparative variables on the properties of poly(dl-lactide-co-glycolide) methoxypoly(ethyleneglycol) copolymers related to their application in controlled drug delivery [J].
Beletsi, A ;
Leontiadis, L ;
Klepetsanis, P ;
Ithakissios, DS ;
Avgoustakis, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 182 (02) :187-197
[7]   Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation:: preparation, characterization and in vitro evaluation [J].
Betancourt, Tania ;
Brown, Brandon ;
Brannon-Peppas, Lisa .
NANOMEDICINE, 2007, 2 (02) :219-232
[8]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[9]   Nanoparticle and targeted systems for cancer therapy [J].
Brannon-Peppas, L ;
Blanchette, JO .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (11) :1649-1659
[10]  
Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO